Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding

J Virol. 2007 Sep;81(17):9584-90. doi: 10.1128/JVI.02782-06. Epub 2007 Jun 20.

Abstract

The hepatitis C virus glycoprotein E2 receptor-binding domain is encompassed by amino acids 384 to 661 (E2(661)) and contains two hypervariable sequences, HVR1 and HVR2. E2 sequence comparisons revealed a third variable region, located between residues 570 and 580, that varies widely between genotypes, designated here as igVR, the intergenotypic variable region. A secreted E2(661) glycoprotein with simultaneous deletions of the three variable sequences retained its ability to bind CD81 and conformation-dependent monoclonal antibodies (MAbs) and displayed enhanced binding to a neutralizing MAb directed to E2 immunogenic domain B. Our data provide insights into the E2 structure by suggesting that the three variable regions reside outside a conserved E2 core.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Monoclonal / metabolism
  • Antibodies, Viral / metabolism
  • Antigens, CD / metabolism*
  • Binding Sites / genetics
  • Hepacivirus / metabolism*
  • Humans
  • Molecular Sequence Data
  • Protein Binding
  • Protein Structure, Tertiary
  • Receptors, Virus / metabolism
  • Sequence Deletion
  • Tetraspanin 28
  • Viral Envelope Proteins / chemistry
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / metabolism*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Antigens, CD
  • CD81 protein, human
  • Receptors, Virus
  • Tetraspanin 28
  • Viral Envelope Proteins
  • glycoprotein E2, Hepatitis C virus